TOGETHER LETâ€™S PREVENT CANCER
TOGETHER LET’S PREVENT CANCER
“Journal of Cancer Epidemiology & Prevention”, welcomes you to the most accessed “open access publication-Insight Medical Publishing (iMedPub)” with 30+ Million reader base.
The geographical distribution of our readership is as follows: India (32%), USA (13%), UK (4.10%), South Africa, Australia, China and Japan. It was observed that there was relatively greater demand for scientific content since the sections on in press, current issues and archived articles recorded highest visibility and readership.
The journal aims to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health professionals in the field of Oncology, to reduce cancer prevalence and mortality.
The scope of the journal includes molecular epidemiology of cancer, health disparities, incidence and mortality, biomarkers, etiology, screening and detection, surveillance, development, risk prediction, control and prevention.
With the years coming, the team “Journal of Cancer Epidemiology & Prevention” has fastened the process of an article publication by providing an acknowledgment within 48 hours and a review report within 21 days.
All accepted articles will be published under CC BY 4.0 license, and meets the open access requirements of funding agencies such as NIH, HHMI, and Welcome Trust. The funded articles are directly submitted to PUBMED